TABRECTA cpr pell 200 mg 120 pce

7680676480028 CH-67648 L01EX17 07.16.1.

Reimbursement limitations:

TABRECTA.01

Après accord de prise en charge des frais par l’assureur-maladie, après consultation préalable du médecin-conseil. …

TABRECTA cpr pell 200 mg 120 pce
TABRECTA cpr pell 200 mg 120 pce
TABRECTA cpr pell 200 mg 120 pce
1 / 3
google

Details

Product number
6764802
CPT
-
Packaging group
120
Unit
Tablette(n)
Composition
capmatinibum 200 mg ut capmatinibi hydrochloridum monohydricum, cellulosum microcristallinum, mannitolum, crospovidonum, povidonum K 30, magnesii stearas, silica colloidalis anhydrica, natrii laurilsulfas corresp. natrium 0.16 mg, Überzug: hypromellosum, E 171, macrogolum 4000, talcum, E 172 (flavum), pro compresso obducto.

Articles (1)

Tabrecta 200 mg, Filmtabletten
Filmtabletten
120
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/09/2024
Patient information leaflet
Français
13/09/2024
Patient information leaflet
Italien
13/09/2024
Professional SmPC
Allemand
26/08/2024
Professional SmPC
Français
26/08/2024
Professional SmPC
Italien
26/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.16 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 5954.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2022

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67648
Drug name
Tabrecta, Filmtabletten
Galenic form
FILM
ATC Code
L01EX17
Authorization status
Z
Dispensation category
A
First authorization
26/04/2021
Authorization expiration date
06/03/2028
IT number
07.16.1.
Domain
Human medicine
Field of application
Nicht-kleinzelliges Lungenkarzinom

Packaging details

Description (FR)
TABRECTA cpr pell 200 mg 120 pce
Description (DE)
TABRECTA Filmtabl 200 mg 120 Stk
Market launch
26/04/2021
Narcotic (BTM)
No

Other packaging sizes

TABRECTA cpr pell 150 mg 120 pce
120 TABL
View